USPTO Biotech/Chemical Partnership (BCP) Meetings

In This Section

Biotechnology/Chemical/Pharmaceutical Customer Partnership - Monday, Dec 9, 2013

Dec 9, 2013, 12:19 PM by AIPLA Admin
Biotechnology/Chemical/Pharmaceutical Customer Partnership
One Hour Delay

Monday, December 9, 2013
United States Patent and Trademark Office
600 Dulany Street, Alexandria, VA
Madison Auditorium

Morning Session

 

 

8:30 – 9:00

Meet and Greet

Wanda Walker, Jerry Lorengo, and James Wilson (Acting), Directors, TC1600, SPEs

9:00 – 9:30

Opening Remarks

Bruce Kisliuk, Deputy Commissioner for Patent Administration

9:30 –9:35

BCP Website

Suzannah K. Sundby, Partner of Smith, Gambrell & Russell, LLP, Chair of the Biotech Committee of AIPLA

9:35 --10:30

Making a Prima Facie Case (in Polymorph Cases)

Bennett Celsa, QAS, TC1600

Janet Andres, SPE, Art Unit 1625

10:30 – 10:45

Break

10:45 – 11:45

Developments in the Patent Prosecution Highway (PPH)

Mark Powell, Special Advisor to the Commissioner for Patents

Lunch and Cake

11:45 – 1:30

 

Afternoon Session

1:30–2:30

Two Recent Supreme Court Cases: Bowman v. Monsanto and Association for Molecular Pathology v. Myriad Genetics

RoberteMakowski, Ph.D., J.D., Senior Counsel, BASF

2:30 – 2:45

Closing Remarks/Discussion

Wanda Walker, Jerry Lorengo, and James Wilson (Acting), Directors, TC1600